Fish Oils and Low-Molecular-Weight Heparin for the Reduction of Restenosis After Percutaneous Transluminal Coronary Angioplasty: The EMPAR Study
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background Percutaneous transluminal coronary angioplasty (PTCA) is complicated by restenosis within 6 months in >40% of patients. Theoretical, animal experimental, and human epidemiological and clinical trial findings have suggested that fish oils (n-3) might reduce restenosis. Low-molecular-weight heparin (LMWH) has reduced cellular proliferation and restenosis in several experimental systems. Methods and Results We randomized 814 patients to fish oils (5.4 g n-3 fatty acids) or placebo a median of 6 days before PTCA and continued for 18 weeks. At the time of sheath removal, 653 patients with at least one successfully dilated lesion were randomized to LMWH (30 mg SC BID) or control for 6 weeks in a 2×2 factorial design. Follow-up with quantitative coronary angiography (QCA; target, 18 weeks) was interpretable on 96% of these patients. Restenosis rates per patient were for n-3, 46.5%; placebo, 44.7%; LMWH, 45.8%; and control, 45.4%. Restenosis rates per lesion were for n-3, 39.7%; placebo, 38.7%; LMWH, 38%; and control, 40.4%. At follow-up QCA, mean minimal lumen diameters were (mm) for n-3, 1.12; placebo, 1.10; LMWH, 1.12; and control, 1.10. Fifteen percent of patients permanently discontinued n-3/placebo before study completion, and 21% of patients discontinued LMWH early. There were no significant differences in the occurrences of ischemic events. Bleeding was more common with LMWH, usually was mild, and led to early discontinuation of study medication in only 0.9% of patients. Gastrointestinal side effects were more common in patients receiving n-3 than placebo. Conclusions There is no evidence for a clinically important reduction of PTCA restenosis in this trial by either n-3 or LMWH. Evaluation of the results for n-3 in the context of previously published data on the reduction of PTCA restenosis indicates that n-3 is not efficacious and that further trials are unwarranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Bairati, I., Roy, L., & Meyer, F. (1992) · Circulation · doi:10.1161/01.cir.85.3.950 · Cited by 150
Cited by
Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2002) · Circulation · doi:10.1161/01.cir.0000038493.65177.94 · Cited by 3,707
Essential fatty acids in health and chronic disease
Simopoulos, A. P. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/70.3.560s · Cited by 1,692
Hirsh, J., Warkentin, T. E., Shaughnessy, S. G., Anand, S. S., Halperin, J. L., Raschke, R., Granger, C., Ohman, E. M., & Dalen, J. E. (2001) · Chest · doi:10.1378/chest.119.1_suppl.64s · Cited by 1,580
Self-citationWeitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Wang, C., Harris, W. S., Chung, M., Lichtenstein, A. H., Balk, E. M., Kupelnick, B., Jordan, H. S., & Lau, J. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/84.1.5 · Cited by 980
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review
Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.02.012 · Cited by 732
Hirsh, J., Anand, S. S., Halperin, J. L., & Fuster, V. (2001) · Circulation · doi:10.1161/01.cir.103.24.2994 · Cited by 565
Self-citationFish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular Disease
Kris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000038493.65177.94 · Cited by 501
von Schacky, C., Angerer, P., Kothny, W., Theisen, K., & Mudra, H. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-7-199904060-00003 · Cited by 487
n−3 Fatty acids and cardiovascular disease
Breslow, J. L. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1477s · Cited by 401
EFSA Panel on Dietetic Products, N. A. A. (. (2012) · EFSA Journal · doi:10.2903/j.efsa.2012.2815 · Cited by 370
Immunonutrition: the role of ω-3 fatty acids
Alexander, J. W. (1998) · Nutrition · doi:10.1016/s0899-9007(98)00004-5 · Cited by 299
Benefits of fish oil supplementation in hyperlipidemia: a systematic review and meta-analysis
Eslick, G. D., Howe, P. R. C., Smith, C., Priest, R., & Bensoussan, A. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.03.092 · Cited by 299
Analysis and Reporting of Factorial Trials: A Systematic Review
McAlister, F. A., Straus, S. E., Sackett, D. L., & Altman, D. G. (2003) · JAMA · doi:10.1001/jama.289.19.2545 · Cited by 288
Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis
West, N. J., Clark, S. K., Phillips, R. K. S., Hutchinson, J. M., Leicester, R. J., Belluzzi, A., & Hull, M. A. (2010) · Gut · doi:10.1136/gut.2009.200642 · Cited by 244
Current Clinical Applications of Ω‐6 and Ω‐3 Fatty Acids
Lee, S., Gura, K. M., Kim, S., Arsenault, D. A., Bistrian, B. R., & Puder, M. (2006) · Nutrition in Clinical Practice · doi:10.1177/0115426506021004323 · Cited by 100
“Selected studies have also shown that -3 fatty acid supplementation improves cardiac status measured by angiography and the survival of vein grafts in coronary bypass graft patients,(26,27) but not restenosis rates in patients undergoing coronary angioplasty.(28,29) Further study, especially in the role of ALA, is war…”
BackgroundWachira, J. K., Larson, M. K., & Harris, W. S. (2014) · British Journal of Nutrition · doi:10.1017/s000711451300425x · Cited by 91
Balk, E. M., Lichtenstein, A. H., Chung, M., Kupelnick, B., Chew, P., & Lau, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.06.042 · Cited by 63
Dinu, M., Sofi, F., Lotti, S., Colombini, B., Mattioli, A. V., Catapano, A. L., Casula, M., Baragetti, A., Wong, N. D., Steg, P. G., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae184 · Cited by 43
Metadata
- Authors
- Cairns, J. A., Gill, J., Morton, B., Roberts, R., Gent, M., Hirsh, J., Holder, D., Finnie, K., Marquis, J. F., Naqvi, S., & Cohen, E.
- Venue
- Circulation
- Published
- 1996-10
- Volume
- 94
- Issue
- 7
- Pages
- 1553-1560
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2129933214
- Cited by
- 157
- References
- 2
- FWCI
- 15.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.